Ligia Gabriela Tătăranu Selected Research

Combined Pituitary Hormone Deficiency

1/2017

Mass effect: a plethora of symptoms caused by an otherwise benign transitional pituitary meningioma. Case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ligia Gabriela Tătăranu Research Topics

Disease

2	Neoplasms (Cancer) 01/2023 - 07/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2023
1	Brain Neoplasms (Brain Tumor) 09/2023
1	Neoplasm Metastasis (Metastasis) 09/2023
1	Acromegaly 01/2023
1	Adenoma (Adenomas) 01/2023
1	Spinal Cord Injuries (Spinal Cord Injury) 11/2022
1	Inflammation (Inflammations) 11/2022
1	Kidney Calculi (Kidney Stone) 10/2022
1	Rheumatic Diseases (Rheumatism) 10/2022
1	Gout 10/2022
1	Ischemic Stroke 10/2022
1	Glioblastoma (Glioblastoma Multiforme) 07/2021
1	Hyperprolactinemia 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017
1	Hypokinesia (Bradykinesia) 01/2017
1	Pathologic Constriction (Stenosis) 01/2017
1	Combined Pituitary Hormone Deficiency 01/2017

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2022
2	LithiumIBA 11/2022 - 10/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2023
1	somatostatin receptor 2IBA 01/2023
1	aryl hydrocarbon receptor-interacting proteinIBA 01/2023
1	pasireotideIBA 01/2023
1	Keratins (Keratin)IBA 01/2023
1	Growth Hormone (Somatotropin)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Cadherins (E-Cadherin)IBA 01/2023
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2023
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2023
1	FilaminsIBA 01/2023
1	CationsIBA 11/2022
1	Ion Channels (Ion Channel)IBA 11/2022
1	CalciumIBA 11/2022
1	MagnesiumIBA 11/2022
1	PotassiumIBA 11/2022
1	mesoglycanIBA 11/2022
1	SodiumIBA 11/2022
1	Monovalent CationsIBA 11/2022
1	SaltsIBA 10/2022
1	ferric oxide (iron oxide)IBA 07/2021
1	cytolysin III (Stoichactis helianthus)IBA 07/2021
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2017
1	MetalsIBA 01/2017

Therapy/Procedure

2	Therapeutics 09/2023 - 01/2023
1	Immunotherapy 09/2023
1	Drug Therapy (Chemotherapy) 09/2023
1	Stents 01/2017
1	Percutaneous Coronary Intervention 01/2017